| Pregnancy outcomes in patients treated with belimumab: report from real-world experience JH Kao, TY Lan, CH Lu, CF Cheng, YM Huang, CY Shen, SC Hsieh Seminars in Arthritis and Rheumatism 51 (5), 963-968, 2021 | 27 | 2021 |
| The critical role of early dengue surveillance and limitations of clinical reporting–implications for non-endemic countries JH Kao, CD Chen, ZR Tiger Li, TC Chan, TH Tung, YH Chu, HY Cheng, ... PloS one 11 (8), e0160230, 2016 | 17 | 2016 |
| Risk of hepatitis b virus (HBV) reactivation in HBsAg-negative, anti-HBc-Negative patients receiving rituximab for autoimmune diseases in HBV endemic areas TY Lan, YC Lin, TC Tseng, HC Yang, JH Kao, CF Cheng, TJ Lee, ... Gut and Liver 17 (2), 288, 2022 | 15 | 2022 |
| Characteristics and potential risk factors of hydroxychloroquine retinopathy in patients with systemic lupus erythematosus: Focusing on Asian population JH Kao, TT Lai, CH Lu, TY Lan, YT Hsieh, CY Shen, KJ Li, SC Hsieh Journal of Ocular Pharmacology and Therapeutics 38 (10), 728-733, 2022 | 6 | 2022 |
| Experience of the use of hydroxychloroquine on patients with COVID-19: A perspective on viral load and cytokine kinetics WD Liu, SY Chang, TY Lan, YC Lin, JH Kao, CH Liao, MJ Tsai, PH Kuo, ... Journal of the Formosan Medical Association 120 (5), 1269-1273, 2021 | 5 | 2021 |
| More steps forward to optimize the dosing of hydroxychloroquine: comment on the article by Petri et al JH Kao, TY Lan, KJ Li Arthritis & Rheumatology 73 (11), 2149-2149, 2021 | 1 | 2021 |
| Risk of rituximab-induced hepatitis B flare after antiviral discontinuation in rheumatic patients with chronic hepatitis B virus. TY Lan, TW Chang, TC Tseng, TJ Lee, JH Kao, CF Cheng, SC Huang, ... Clinical and Experimental Rheumatology, 2024 | | 2024 |
| More Considerations for Risk Stratification of Fetal Atrioventricular Block Beyond Anti‐Ro Titer: comment on the article by Buyon et al JH Kao, CF Su Arthritis & Rheumatology 76 (6), 985-986, 2024 | | 2024 |
| Correlation of hydroxychloroquine blood levels and QTc interval in Taiwan: a pilot study in a tertiary medical center 藍士勛， 高瑞鴻， 謝松洲， 李克仁 Formosan Journal of Rheumatology 37 (2), 79-86, 2023 | | 2023 |
| The significance of dense fine speckled pattern in antinuclear antibody‐associated rheumatic disease and coexisting autoantibodies: A propensity score‐matched cohort study CF Cheng, TY Lan, JH Kao, CH Lu, YC Chang, YM Huang, FJ Yang, ... International Journal of Rheumatic Diseases 26 (9), 1667-1675, 2023 | | 2023 |
| Correlation of hydroxychloroquine blood levels and flare risk in patients with systemic lupus erythematosus in Taiwan: a pilot study in a tertiary medical center 張庭暐， 高瑞鴻， 謝松洲， 李克仁 Formosan Journal of Rheumatology 37 (1), 43-51, 2023 | | 2023 |
| High risk of hepatitis virus B associated hepatitis flare in rheumatoid arthritis patients with chronic hepatitis B virus infection receiving abatacept TY Lan, CF Cheng, TJ Lee, JH Kao, CY Shen, SC Hsieh, KJ Li Formosan Journal of Rheumatology 35 (2), 63-69, 2021 | | 2021 |
| Prevalence of ocular diseases in patients with systemic lupus erythematosus: a single center experience retrospective analysis JH Kao, SC Hsieh Formosan Journal of Rheumatology 35 (2), 35-40, 2021 | | 2021 |
| Risk of Hepatitis B Virus Reactivation in HBsAg-negative, Anti-HBc-negative Patients Receiving Rituximab for Autoimmune Diseases in Hepatitis B Virus Endemic Areas TY Lan, YC Lin, TC Tseng, HC Yang, JH Kao, CF Cheng, TJ Lee, ... | | 2021 |
| Hydroxychloroquine retinal toxicity JH Kao, KJ Li Formosan Journal of Rheumatology 33 (2), 67-67, 2019 | | 2019 |
